UOC
ATRC icon

UBS O'Connor’s AtriCure ATRC Stock Holding History

UBS O'Connor’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,199
Closed -$435K – 523
2023
Q4 		$435K Sell
12,199
-37,094
-75% -$1.38M 0.01% 367
2023
Q3 		$2.16M Buy
49,293
+9,000
+22% +$439K 0.04% 234
2023
Q2 		$1.99M Sell
40,293
-867
-2% -$40K 0.04% 291
2023
Q1 		$1.71M Sell
41,160
-6,540
-14% -$271K 0.04% 350
2022
Q4 		$2.12M Buy
47,700
+35,400
+288% +$1.48M 0.04% 456
2022
Q3 		$481K Buy
+12,300
New +$563K 0.01% 813
2015
Q3 		– Sell
-50,000
Closed -$1.23M – 533
2015
Q2 		$1.23M Sell
50,000
-30,000
-38% -$670K 0.01% 534
2015
Q1 		$1.64M Buy
80,000
+20,000
+33% +$387K 0.02% 448
2014
Q4 		$1.2M Hold
60,000
– – 0.02% 337
2014
Q3 		$883K Buy
60,000
+20,000
+50% +$319K 0.02% 358
2014
Q2 		$735K Sell
40,000
-10,000
-20% -$166K ﹤0.01% 349
2014
Q1 		$940K Buy
+50,000
New +$1.02M 0.02% 329

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS O'Connor's ATRC Position: Q1 2024 in Review

UBS O'Connor sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 12,199 shares — an estimated $435K sold.

UBS O'Connor first reported a position in ATRC in Q1 2014 and held it in 12 quarters. The position peaked at $2.16M in Q3 2023. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

  • UBS O'Connor reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
  • UBS O'Connor sold 12,199 AtriCure shares in Q1 2024, an estimated $435K.
  • UBS O'Connor first reported a position in AtriCure in Q1 2014 and held it in 12 quarters.
  • UBS O'Connor's AtriCure position peaked at $2.16M in Q3 2023.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.